You searched for Humanized antibody - Page 42 of 45

News and Trends 21 Feb 2018

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

…type of monoclonal antibody known as a checkpoint inhibitor that targets the immune regulatory molecule PD-L1. The FDA approval for Imfinzi is the first authorization of a treatment for lung…

February 21, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 12 Jun 2017

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced…

June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 8 Oct 2019

Biotech Hubs: A Tale of Two Cities

…founded the online antibody provider Abcam in 1998. Under his leadership, the company grew to be worth over €2B today. Having met with success, Milner became an angel investor in…

October 8, 2019 - 6 minutesmins - By Jonathan Smith

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

…the vaccination route and frequency, thus impacting the design of the immunization program. The breakthrough COVID-19 vaccines underwent the same checks and balances, with antibody detection methods of ELISA and…

November 3, 2022 - 8 minutesmins - By Sudha Sundaram

News and Trends 1 Nov 2018

Llama Antibodies Could Be the Key to Universal Flu Prevention

…or different targets.” Indeed, the antibody developed by the group was built using four different llama antibodies, two targeting influenza A viruses and two targeting influenza B viruses to cover…

November 1, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 15 Mar 2017

What are the Best Countries to Recruit Biotech Talents in 2017?

…Ablynx owns Nanobodies, smaller antibody fragments, and has a market cap of €800M. Biocartis develops molecular diagnostics for personalized medicine, with a market cap of €460M. TiGenix has stem cell…

March 15, 2017 - 10 minutesmins - By External Contributor

novo nordisk staten fat hypertriglyceridemia cardiovascular disease

News and Trends 17 Dec 2018

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease

…with high triglycerides and higher cardiovascular risk. Staten’s lead candidate, licensed from Belgian biotech argenx, is a human antibody that targets ApoC3, reducing fatty molecules in the blood. Though the…

December 17, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 25 Apr 2017

Novartis Negotiates its Way into the US Migraine Market

…human monoclonal antibody, which targets the Calcitonin Gene-Related Peptide (CGRP) receptor. CGRP is thought to play a crucial role in mediating the incapacitating pain of migraine and increased blood levels…

April 25, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 2 Mar 2016

New Joint Venture to Shake Up Immuno-Oncology in the UK

…treatments both for solid tumours and leukaemias. This is not an unusual strategy. In the past, Amgen bought Micromet’s antibody constructs, and AstraZeneca acquired Spirogen and their antibody ‘warheads‘. And…

March 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 17 Oct 2022

Ophthalmology biopharma company Oculis combines with EBAC

…treatment of inflammation and pain following cataract surgery, which would, if approved, potentially be the first once-a-day steroid for this indication. OCS-02 OCS-02 is a topical anti-TNF alpha monoclonal antibody…

October 17, 2022 - 5 minutesmins - By Jim Cornall

Best in Biotech 11 Jul 2024

From data to discovery: Five bioinformatics companies you should know in 2024

…the library, which is validated by next-generation sequencing. Last month, it reported the discovery of TB206-001, an antibody designed to improve cancer treatment, through its silicon platform. Twist has had…

July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 16 Apr 2024

Seven biotech companies climbing their way up in Colorado

…$4 million public offering. BioLoomics Based in Boulder, Colorado, BioLoomics is a biotech company that develops targeted antibody therapies. Late last year, it raised $8.7 million in a seed round…

April 16, 2024 - 8 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

Biotech Hubs: A Tale of Two Cities

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

Llama Antibodies Could Be the Key to Universal Flu Prevention

What are the Best Countries to Recruit Biotech Talents in 2017?

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease

Novartis Negotiates its Way into the US Migraine Market

New Joint Venture to Shake Up Immuno-Oncology in the UK

Ophthalmology biopharma company Oculis combines with EBAC

From data to discovery: Five bioinformatics companies you should know in 2024

Seven biotech companies climbing their way up in Colorado

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!